Skip to content
★ Sign in to follow
QB

Q BioMed Inc. Stock: price and insider trades · United States

Q BioMed Inc.: what insiders have been doing

Q BioMed Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Q BioMed Inc. has published a filing in the past twelve months. The most recent one dates from 31 May 2022.

Our records for Q BioMed Inc. go back to 2016, with no purchases and 37 sales on the open market in total.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
50
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€516,027
37 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2022

FY ended November 2022 · cache

Income statement
RevenueUS$253.1k
Gross profit-US$8k-3% margin
Net income-US$1.8M-721.7% margin
Last declaration on 31 May 2022
Declarations50 total
  • ◆
    Chief Executive OfficerExecutives
    4B USD30SEC
    200,000 shares@ US$20,000.00100.0% of flowCommon StockSEC:0001104659-22-066485:0
  • ◆
    Chief Legal OfficerExecutives
    6B USD19SEC
    250,000 shares@ US$25,000.00100.0% of flowCommon StockSEC:0001104659-22-066487:0
  • ◆
    Chief Legal OfficerExecutives
    0SEC
    35,000 sharesCommon stockSEC:0001104659-21-028932:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 sharesCommon StockSEC:0001732600-19-000001:2
  • ◆
    DirectorExecutives
    0SEC
    1,000 sharesCommon StockSEC:0001732600-19-000001:3
  • ◆
    DirectorExecutives
    0SEC
    1,500 sharesCommon StockSEC:0001732600-19-000001:4
  • ◆
    DirectorExecutives
    0SEC
    500 sharesCommon StockSEC:0001732600-19-000001:5
  • ◆
    DirectorExecutives
    0SEC
    2,000 sharesCommon StockSEC:0001732600-19-000001:6
  • ◆
    DirectorExecutives
    0SEC
    500 sharesCommon StockSEC:0001732600-19-000001:7
  • ◆
    DirectorExecutives
    0SEC
    1,500 sharesCommon StockSEC:0001732600-19-000001:1
  • ◆
    DirectorExecutives
    0SEC
    1,500 sharesCommon StockSEC:0001732600-19-000001:0
  • ◆
    Chief Legal OfficerExecutives
    0SEC
    115,761 sharesCommon StockSEC:0001461959-19-000001:0
  • ▼
    Chief Executive OfficerExecutives
    13,504 USD0SEC
    6,400 shares@ US$2.11Common StockSEC:0001405626-19-000001:0
  • ▼
    Chief Executive OfficerExecutives
    23,590 USD23SEC
    7,000 shares@ US$3.3711.9% of flowCommon StockSEC:0001405626-18-000008:0
  • ▼
    Chief Executive OfficerExecutives
    19,950 USD23SEC
    7,000 shares@ US$2.8510.1% of flowCommon StockSEC:0001405626-18-000008:1
  • ▼
    Chief Executive OfficerExecutives
    23,364 USD23SEC
    6,600 shares@ US$3.5411.8% of flowCommon StockSEC:0001405626-18-000007:0
  • ▼
    Chief Executive OfficerExecutives
    24,702 USD23SEC
    6,900 shares@ US$3.5812.5% of flowCommon StockSEC:0001405626-18-000007:1
  • ▼
    Chief Executive OfficerExecutives
    6,840 USD22SEC
    2,000 shares@ US$3.423.5% of flowCommon StockSEC:0001405626-18-000006:0
  • ▼
    Chief Executive OfficerExecutives
    7,612 USD22SEC
    2,200 shares@ US$3.463.9% of flowCommon StockSEC:0001405626-18-000006:1
  • ▼
    Chief Executive OfficerExecutives
    17,967 USD23SEC
    5,300 shares@ US$3.399.2% of flowCommon StockSEC:0001405626-18-000005:0
  • ▼
    Chief Executive OfficerExecutives
    7,140 USD22SEC
    2,100 shares@ US$3.403.7% of flowCommon StockSEC:0001405626-18-000005:1
  • ▼
    Chief Executive OfficerExecutives
    13,034 USD23SEC
    3,800 shares@ US$3.436.6% of flowCommon StockSEC:0001405626-18-000004:1
  • ▼
    Chief Executive OfficerExecutives
    16,856 USD23SEC
    4,900 shares@ US$3.448.6% of flowCommon StockSEC:0001405626-18-000004:2
  • ▼
    Chief Executive OfficerExecutives
    4,788 USD22SEC
    1,400 shares@ US$3.422.4% of flowCommon StockSEC:0001405626-18-000004:0
  • ▼
    Chief Executive OfficerExecutives
    19,779 USD23SEC
    5,700 shares@ US$3.4710.1% of flowCommon StockSEC:0001405626-18-000003:0

25 of 50 declarations

About Q BioMed Inc.

Q BioMed Inc. is a biotechnology company focused on the development and commercialization of pharmaceutical products for serious diseases. It aims to improve patients' quality of life through innovative solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations